Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.29B | 22.37B | 21.20B | 21.01B | 20.30B | 20.73B |
Gross Profit | 22.14B | 0.00 | 21.20B | 21.01B | 20.30B | 20.73B |
EBITDA | 2.37B | 790.00M | 2.72B | 3.33B | 3.21B | 2.64B |
Net Income | 832.00M | 861.00M | 1.25B | 1.60B | 1.61B | 877.00M |
Balance Sheet | ||||||
Total Assets | 1.15T | 1.15T | 1.14T | 1.19T | 1.21T | 1.24T |
Cash, Cash Equivalents and Short-Term Investments | 57.26B | 0.00 | 64.52B | 108.97B | 128.42B | 160.63B |
Total Debt | 51.44B | 54.46B | 43.34B | 66.05B | 102.52B | 105.81B |
Total Liabilities | 1.09T | 1.10T | 1.08T | 1.11T | 1.14T | 1.17T |
Stockholders Equity | 55.51B | 50.70B | 58.65B | 73.77B | 71.32B | 72.55B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 9.13B | -23.71B | -32.97B | -35.05B | 79.31B |
Operating Cash Flow | 0.00 | 9.37B | -21.82B | -31.98B | -34.28B | 80.49B |
Investing Cash Flow | 0.00 | 8.33B | -5.94B | 6.11B | 2.49B | -513.00M |
Financing Cash Flow | 0.00 | 14.03B | -17.96B | 6.35B | -462.00M | 74.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥973.27B | 13.07 | 6.30% | 3.23% | 9.27% | 20.49% | |
70 Outperform | ¥766.79B | 10.47 | 7.30% | 3.50% | 15.35% | -1.62% | |
68 Neutral | ¥724.27B | 10.74 | 7.55% | 3.29% | 7.97% | 15.90% | |
66 Neutral | ¥86.46B | 10.76 | 3.25% | -6.07% | 21.28% | ||
62 Neutral | ¥7.87B | 10.59 | 3.86% | -1.88% | -57.55% |